In the field of key layout, the company has successfully developed and listed 45 new products, which is in a leading position in the segmented field in China. At present, the company's research and development focus is mainly focused on two aspects: small molecule chemical innovative drugs, innovative chemical generic drugs.
40item
Small molecule innovative drugs in development
13item
Investigational New Drug Application
7item
New drug applications NDA
